About
Embleema’s standard technology platform accelerates personalized medicine by expediting evidence generation and regulatory reviews of new treatments. From establishing trusted real-world and clinical data networks to making complex data sets regulatory grade, Embleema helps its clients from life sciences, academia, regulatory agencies, and patient advocacy build a healthier world.
Founders Bio
Before founding Embleema, Robert Chu was the former SVP Global Technology Solutions at IQVIA, the leader in clinical trials and health data. He held several senior management positions in the area of healthcare technology and consulting in Europe, Asia and the U.S. Robert started his career at IBM as a software engineer and has a Master Degree in Computer Science.
Honors & Awards
Embleema has received the first prize at the HL7 FHIR DevDays event in 2020. HL7 is the international standardization body for health data interoperability.